Andrew Yau Wah Young*, Cheng Yo Yen and Chil Hsin Hung
Volume4-Issue1
Dates: Received: 2022-12-13 | Accepted: 2023-01-02 | Published: 2023-01-04
Pages: 005-007
Abstract
Combine modality anti-cancer treatment, Concurrent Chemo-Radio Therapy (CCRT) is a recommended approach for relatively resistant tumor in clinical oncology. But it is relatively more toxic to patient, and severely disrupt patient’s quality of life due to systemic side-effects causing by intravenous cytotoxic drugs delivery, especially for those fragile advanced cancer patients. Intra-arterial infusion chemotherapy is another option for CCRT because of not only a better tumor respond documented, and also bonus a better quality of life improvement.
We demonstrated an advanced buccal cancer patient who had been heavily treated, but rapidly recurrence head and neck tumor for salvage treatment with Intra-Arterial Concurrent Chemo-Radio Therapy (IACCRT). Complete tumor respond was resulted, and also restored a very satisfactory gain on quality of life, ECOG had been improved from score 3 to 1. We concluded that IACCRT is a feasible treatment choice for fragile advanced cancer patient.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1642
Certificate of Publication
Copyright
© 2023 Wah Young AY, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Wah Young AY, Yen CY, Hung CH. Intra-Arterial Concurrent Chemo Radio Therapy (IACCRT) can be a Feasible Salvage Treatment for Fragile Advanced Cancer Patient to Restore Better Quality of Life. 2022 Jan 04; 4(1): 005-007. doi: 10.37871/jbres1642, Article ID: JBRES1642, Available at: https://www.jelsciences.com/articles/jbres1642.pdf
Subject area(s)
References
- Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm--general principles. Nat Clin Pract Oncol. 2007 Feb;4(2):86-100. doi: 10.1038/ncponc0714. PMID: 17259930.
- Hennequin C, Favaudon V. Biological basis for chemo-radiotherapy interactions. Eur J Cancer. 2002 Jan;38(2):223-30. doi: 10.1016/s0959-8049(01)00360-4. PMID: 11803139.
- Chen Q, Zhang B, Dong Y, Mo X, Zhang L, Huang W, Jiang H, Xia J, Zhang S. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis. BMC Cancer. 2018 Apr 27;18(1):486. doi: 10.1186/s12885-018-4406-6. PMID: 29703164; PMCID: PMC5924469.
- Homma A, Onimaru R, Matsuura K, Robbins KT, Fujii M. Intra-arterial chemoradiotherapy for head and neck cancer. Jpn J Clin Oncol. 2016 Jan;46(1):4-12. doi: 10.1093/jjco/hyv151. Epub 2015 Oct 20. PMID: 26486825.
- Yoshizaki T, Kondo S, Wakisaka N, Murono S, Kitagawa N, Tsuji A, Nakashima M, Sanada J, Matsui O. Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):172-8. doi: 10.1177/000348940911800303. PMID: 19374147.
